Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin HanHong Biotech is a specialized biotechnology company headquartered in Tianjin, China, that focuses on the development and production of unnatural amino acids, peptides, and high-end pharmaceutical intermediates. The company offers a comprehensive suite of services including custom synthesis, process optimization, and large-scale manufacturing to support the global life sciences industry. Their product catalog features a wide array of protected amino acids and chiral building blocks essential for modern drug discovery. Operating as both a CRO and CDMO, HanHong Biotech leverages advanced chemical technologies such as asymmetric synthesis and catalytic hydrogenation. The firm serves a diverse clientele ranging from academic research institutions to major international pharmaceutical corporations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin HanHong Biotech.